Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.71% |
| 2 | Healthcare | 11.34% |
| 3 | Financials | 9.38% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
State Street SPDR S&P Pharmaceuticals ETF
XPH
$511M
| $31.3M | ﹤0.01% |
779,019
+109,463
| +16% | +$4.68M |
|
|
FEI
1727
DELISTED
FIRST TRUST MLP AND ENERGY INCOME FUND
FEI
| $31.3M | ﹤0.01% |
4,374,954
-85,851
| -2% | -$684K |
|
1728
First Trust Dorsey Wright Dynamic Focus 5 ETF
FVC
$111M
| $31.2M | ﹤0.01% |
934,408
+137,477
| +17% | +$4.8M |
|
1729
Prestige Consumer Healthcare
PBH
$2.43B
| $31.2M | ﹤0.01% |
626,308
-83,394
| -12% | -$4.62M |
|
|
SLY
1730
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $31.2M | ﹤0.01% |
411,787
+5,217
| +1% | +$439K |
|
|
MMU
1731
Western Asset Managed Municipals Fund
MMU
$558M
| $31.1M | ﹤0.01% |
3,209,939
+94,474
| +3% | +$1.01M |
|
1732
Brunswick
BC
$5.29B
| $31.1M | ﹤0.01% |
475,462
-152,187
| -24% | -$11.4M |
|
1733
iShares Core US REIT ETF
USRT
$4.63B
| $31.1M | ﹤0.01% |
655,116
+17,765
| +3% | +$978K |
|
1734
Dillards
DDS
$9.59B
| $31.1M | ﹤0.01% |
113,959
+10,220
| +10% | +$2.7M |
|
1735
Phillips Edison & Co
PECO
$5.2B
| $31.1M | ﹤0.01% |
1,107,139
-183,779
| -14% | -$6.04M |
|
1736
Assured Guaranty
AGO
$3.35B
| $31.1M | ﹤0.01% |
640,966
-50,244
| -7% | -$2.7M |
|
|
GRID
1737
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund
GRID
$12.3B
| $31M | ﹤0.01% |
412,288
-4,944
| -1% | -$415K |
|
|
SF
1738
Stifel
SF
$12.9B
| $31M | ﹤0.01% |
896,015
-78,412
| -8% | -$3.09M |
|
1739
Jefferies Financial Group
JEF
$12.9B
| $31M | ﹤0.01% |
1,099,079
-170,122
| -13% | -$5.15M |
|
1740
Plains GP Holdings
PAGP
$5.04B
| $31M | ﹤0.01% |
2,839,225
+931,337
| +49% | +$10.7M |
|
1741
U-Haul Holding Co
UHAL
$14.4B
| $31M | ﹤0.01% |
607,860
+19,350
| +3% | +$1.01M |
|
1742
NatWest
NWG
$76.9B
| $30.9M | ﹤0.01% |
6,200,860
-226,691
| -4% | -$1.4M |
|
1743
Pulmonx
LUNG
$92.8M
| $30.9M | ﹤0.01% |
1,853,823
-273,948
| -13% | -$5.04M |
|
1744
Medifast
MED
$128M
| $30.9M | ﹤0.01% |
284,981
+132,834
| +87% | +$19M |
|
1745
Houlihan Lokey
HLI
$9.24B
| $30.8M | ﹤0.01% |
409,086
-21,307
| -5% | -$1.73M |
|
1746
Ionis Pharmaceuticals
IONS
$9.28B
| $30.8M | ﹤0.01% |
696,538
-41,439
| -6% | -$1.75M |
|
1747
Haleon
HLN
$43.2B
| $30.8M | ﹤0.01% |
+5,058,536
| New | +$32.7M |
|
1748
Affiliated Managers Group
AMG
$9.7B
| $30.8M | ﹤0.01% |
275,251
+38,916
| +16% | +$4.88M |
|
1749
ICU Medical
ICUI
$4.58B
| $30.7M | ﹤0.01% |
203,900
+91,244
| +81% | +$15.2M |
|
1750
Fate Therapeutics
FATE
$294M
| $30.7M | ﹤0.01% |
1,369,721
-254,548
| -16% | -$7.35M |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.